Circio Holding ASA – Exercise of Warrants by primary insider
Oslo, Norway 9 December 2024, Circio Holding ASA (OSE: CRNA) Reference is made to the stock exchange announcement on 4 December 2024 regarding commencement of the exercise period for Warrants from 4-18 December 2024 (the "Exercise Period"). BioPharma Drug Licensing Group SL ("BioPharma"), a company owned by Lubor Gaal, the CFO of Circio, has on 6 December 2024 exercised a total of 93,600 Warrants, for the allocation of 93,600 New Shares in the Company at a price per New Share of NOK 0.60. This represents all of the Warrants issued to BioPharma in connection with the Rights Issue